Strides Pharma Science Q4 net profit zooms 317.01% at Rs 200.50 cr
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
The company reported standalone net profit of Rs 200.50 crore for the quarter ended March 31, 2022 as compared to Rs 48.08 crore in the same period last year, registering a year-on-year growth of 317.01 per cent. Net revenue of the company declined substantially by 28.08 per cent at Rs 455.66 crore in January-March quarter of this fiscal as against Rs 633.60 crore in the corresponding period last year. During January-March quarter, operating expenses dropped by 19.75 per cent to Rs 437.82 crore from Rs 545.58 crore in year ago period.
Other Income grew by 263.92 per cent at Rs 84.83 crore versus (Mar'21 Rs 23.31 crore). Operating Profit slipped by 79.74 per cent to Rs 17.83 crore as against Rs 88.02 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 71.85 per cent in March quarter. Interest grew by 20.32 per cent y-o-y to Rs 21.55 crore, while Taxation decreased by 797.38 per cent at Rs -143.80 crore (Mar'21 Rs 20.62 crore).
